The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Diphtheria Toxoid-Global Market Insights and Sales Trends 2025
Synopsis
Diphtheria toxoid is a biological product that is detoxified by diphtheria toxin plus formaldehyde at a certain temperature and becomes non-toxic while still maintaining immunogenicity. It is the most effective preparation to prevent diphtheria.
The global Diphtheria Toxoid market size is expected to reach US$ 315.6 million by 2029, growing at a CAGR of 5.8% from 2023 to 2029. The market is mainly driven by the significant applications of Diphtheria Toxoid in various end use industries. The expanding demands from the Hospitals, Clinics and Ambulatory Surgical Centers,, are propelling Diphtheria Toxoid market. Reducing Toxin, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Denatured Toxin segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Diphtheria Toxoid market, driven by demand from China, the second largest economy with some signs of stabilising, the Diphtheria Toxoid market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Diphtheria Toxoid, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Diphtheria Toxoid market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Diphtheria Toxoid market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Diphtheria Toxoid sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Diphtheria Toxoid covered in this report include Biocompare, GSK, Zoetis, Sanofi and Merck, etc.
The global Diphtheria Toxoid market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Biocompare
GSK
Zoetis
Sanofi
Merck
Global Diphtheria Toxoid market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Diphtheria Toxoid market, Segment by Type:
Reducing Toxin
Denatured Toxin
Global Diphtheria Toxoid market, by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Diphtheria Toxoid companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Diphtheria toxoid is a biological product that is detoxified by diphtheria toxin plus formaldehyde at a certain temperature and becomes non-toxic while still maintaining immunogenicity. It is the most effective preparation to prevent diphtheria.
The global Diphtheria Toxoid market size is expected to reach US$ 315.6 million by 2029, growing at a CAGR of 5.8% from 2023 to 2029. The market is mainly driven by the significant applications of Diphtheria Toxoid in various end use industries. The expanding demands from the Hospitals, Clinics and Ambulatory Surgical Centers,, are propelling Diphtheria Toxoid market. Reducing Toxin, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Denatured Toxin segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Diphtheria Toxoid market, driven by demand from China, the second largest economy with some signs of stabilising, the Diphtheria Toxoid market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Diphtheria Toxoid, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Diphtheria Toxoid market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Diphtheria Toxoid market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Diphtheria Toxoid sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Diphtheria Toxoid covered in this report include Biocompare, GSK, Zoetis, Sanofi and Merck, etc.
The global Diphtheria Toxoid market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Biocompare
GSK
Zoetis
Sanofi
Merck
Global Diphtheria Toxoid market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Diphtheria Toxoid market, Segment by Type:
Reducing Toxin
Denatured Toxin
Global Diphtheria Toxoid market, by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Diphtheria Toxoid companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Diphtheria Toxoid
1.1 Diphtheria Toxoid Market Overview
1.1.1 Diphtheria Toxoid Product Scope
1.1.2 Diphtheria Toxoid Market Status and Outlook
1.2 Global Diphtheria Toxoid Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Diphtheria Toxoid Market Size by Region (2018-2029)
1.4 Global Diphtheria Toxoid Historic Market Size by Region (2018-2023)
1.5 Global Diphtheria Toxoid Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Diphtheria Toxoid Market Size (2018-2029)
1.6.1 North America Diphtheria Toxoid Market Size (2018-2029)
1.6.2 Europe Diphtheria Toxoid Market Size (2018-2029)
1.6.3 Asia-Pacific Diphtheria Toxoid Market Size (2018-2029)
1.6.4 Latin America Diphtheria Toxoid Market Size (2018-2029)
1.6.5 Middle East & Africa Diphtheria Toxoid Market Size (2018-2029)
2 Diphtheria Toxoid Market by Type
2.1 Introduction
2.1.1 Reducing Toxin
2.1.2 Denatured Toxin
2.2 Global Diphtheria Toxoid Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Diphtheria Toxoid Historic Market Size by Type (2018-2023)
2.2.2 Global Diphtheria Toxoid Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Diphtheria Toxoid Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Diphtheria Toxoid Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Diphtheria Toxoid Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Diphtheria Toxoid Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Diphtheria Toxoid Revenue Breakdown by Type (2018-2029)
3 Diphtheria Toxoid Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Ambulatory Surgical Centers
3.2 Global Diphtheria Toxoid Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Diphtheria Toxoid Historic Market Size by Application (2018-2023)
3.2.2 Global Diphtheria Toxoid Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Diphtheria Toxoid Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Diphtheria Toxoid Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Diphtheria Toxoid Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Diphtheria Toxoid Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Diphtheria Toxoid Revenue Breakdown by Application (2018-2029)
4 Diphtheria Toxoid Competition Analysis by Players
4.1 Global Diphtheria Toxoid Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Diphtheria Toxoid as of 2022)
4.3 Date of Key Players Enter into Diphtheria Toxoid Market
4.4 Global Top Players Diphtheria Toxoid Headquarters and Area Served
4.5 Key Players Diphtheria Toxoid Product Solution and Service
4.6 Competitive Status
4.6.1 Diphtheria Toxoid Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Biocompare
5.1.1 Biocompare Profile
5.1.2 Biocompare Main Business
5.1.3 Biocompare Diphtheria Toxoid Products, Services and Solutions
5.1.4 Biocompare Diphtheria Toxoid Revenue (US$ Million) & (2018-2023)
5.1.5 Biocompare Recent Developments
5.2 GSK
5.2.1 GSK Profile
5.2.2 GSK Main Business
5.2.3 GSK Diphtheria Toxoid Products, Services and Solutions
5.2.4 GSK Diphtheria Toxoid Revenue (US$ Million) & (2018-2023)
5.2.5 GSK Recent Developments
5.3 Zoetis
5.3.1 Zoetis Profile
5.3.2 Zoetis Main Business
5.3.3 Zoetis Diphtheria Toxoid Products, Services and Solutions
5.3.4 Zoetis Diphtheria Toxoid Revenue (US$ Million) & (2018-2023)
5.3.5 Sanofi Recent Developments
5.4 Sanofi
5.4.1 Sanofi Profile
5.4.2 Sanofi Main Business
5.4.3 Sanofi Diphtheria Toxoid Products, Services and Solutions
5.4.4 Sanofi Diphtheria Toxoid Revenue (US$ Million) & (2018-2023)
5.4.5 Sanofi Recent Developments
5.5 Merck
5.5.1 Merck Profile
5.5.2 Merck Main Business
5.5.3 Merck Diphtheria Toxoid Products, Services and Solutions
5.5.4 Merck Diphtheria Toxoid Revenue (US$ Million) & (2018-2023)
5.5.5 Merck Recent Developments
6 North America
6.1 North America Diphtheria Toxoid Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Diphtheria Toxoid Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Diphtheria Toxoid Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Diphtheria Toxoid Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Diphtheria Toxoid Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Diphtheria Toxoid Market Dynamics
11.1 Diphtheria Toxoid Industry Trends
11.2 Diphtheria Toxoid Market Drivers
11.3 Diphtheria Toxoid Market Challenges
11.4 Diphtheria Toxoid Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
